← All companies
ONC
BeOne Medicines AG
$313.77
-8.31 -2.58%
Key statistics
from XBRL data in SEC filingsMarket cap
$453B
Revenue (TTM)
$5.74B
Net income (TTM)
$513M
EPS (TTM)
$0.34
P/E ratio
922.9
Dividend yield
—
Free cash flow
$942M
Cash
$4.79B
Total assets
$8.55B
Gross margin
88.3%
52-week range
$253.95 – $385.22
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Other events
Jun 26, 2026
8-K
Director or officer change; Shareholder vote results
Jun 11, 2026
8-K
Other events
May 15, 2026
10-Q
Quarter ended 2026-03-31
May 6, 2026
8-K
Results of operations (earnings release)
May 6, 2026
8-K
Results of operations (earnings release)
Apr 14, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release)
Feb 26, 2026
8-K
Terminated a material agreement
Dec 19, 2025
8-K
Director or officer change
Dec 18, 2025
8-K
Entered a material agreement; Took on a direct financial obligation
Nov 19, 2025
10-Q
Quarter ended 2025-09-30
Nov 6, 2025
8-K
Results of operations (earnings release)
Nov 6, 2025
8-K
Results of operations (earnings release)
Aug 29, 2025
8-K
Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure
Aug 25, 2025
10-Q
Quarter ended 2025-06-30
Aug 6, 2025
8-K
Results of operations (earnings release)
Aug 6, 2025
8-K
Shareholder vote results
May 21, 2025
8-K
Unregistered sale of equity
May 13, 2025
10-Q
Quarter ended 2025-03-31
May 7, 2025
8-K
Results of operations (earnings release)
May 7, 2025
8-K
Other events
Apr 29, 2025
8-K
Shareholder vote results
Apr 28, 2025
8-K
Results of operations (earnings release)
Apr 28, 2025
10-K/A
Fiscal year ended 2024-12-31
Feb 28, 2025
10-K
Fiscal year ended 2024-12-31
Feb 27, 2025
8-K
Results of operations (earnings release)
Feb 27, 2025
8-K
Regulation FD disclosure
Jan 13, 2025
10-K/A
Fiscal year ended 2023-12-31
Jan 8, 2025
8-K
Other events
Dec 23, 2024
8-K
Entered a material agreement; Took on a direct financial obligation
Dec 10, 2024
8-K
Other events
Nov 19, 2024
8-K
Other events
Nov 14, 2024
10-Q
Quarter ended 2024-09-30
Nov 12, 2024
8-K
Results of operations (earnings release); Other events
Nov 12, 2024
8-K
Other events
Oct 28, 2024
8-K
Other events
Sep 30, 2024
8-K
Director or officer change
Sep 26, 2024
8-K
Results of operations (earnings release)
Aug 29, 2024
10-Q
Quarter ended 2024-06-30
Aug 7, 2024